Report overview
Cervical screening is the process of recognizing and expelling abnormal tissue or cells in the cervix before precancerous cervical lesions or cervical malignancy develops.
This report contains market size and forecasts of Cervical Cancer Screening in Global, including the following market information:
Global Cervical Cancer Screening Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cervical Cancer Screening market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pap Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cervical Cancer Screening include Abbott Laboratories, Hologic, Qiagen, Hoffmann-La Roche, Quest Diagnostics, Becton, Dickinson and OncoHealth, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cervical Cancer Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cervical Cancer Screening Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cervical Cancer Screening Market Segment Percentages, by Type, 2021 (%)
Pap Tests
HPV Test
Visual Inspection Using Acetic Acid
Global Cervical Cancer Screening Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cervical Cancer Screening Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostic Laboratories
Clinics
Community Health Center
Global Cervical Cancer Screening Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cervical Cancer Screening Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cervical Cancer Screening revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cervical Cancer Screening revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Hologic
Qiagen
Hoffmann-La Roche
Quest Diagnostics
Becton
Dickinson
OncoHealth
